PubMedCrossRef 34. Backer MV, Kamel N, Sandoval C, Jayabose S, Mendola CE, Backer JM: Overexpression of NM23–1 enhances responsiveness of IMR-32 human neuroblastoma cells to differentiation stimuli. Anticancer Res 2000, 20:1743–1749.PubMed URMC-099 ic50 35. Negroni A, Venturelli D, Tanno B, Amendola R, Ransac S, Cesi V, Calabretta B, Raschella G: Neuroblastoma specific effects of DR-nm23 and its NSC 683864 mouse mutant forms on differentiation and apoptosis. Cell Death Differ 2000, 7:843–850.PubMedCrossRef 36. De los Santos M, Zambrano A, Aranda A: Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. Mol Cancer Ther 2007, 6:1425–1432.PubMedCrossRef 37. Shim KS, Rosner M, Freilinger
A, Lubec G, Hengstschläger M: Bach2 is involved in neuronal differentiation of N1E-115
neuroblastoma cells. Exp Cell Res 2006, 312:2264–2278.PubMedCrossRef 38. Araki T, Zimonjic DB, Popescu NC, Milbrandt J: Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule. J Biol Chem 1997, 272:21373–21380.PubMedCrossRef 39. Chambaut-Guerin AM, Martinez MC, Hamimi C, Gauthereau X, Nunez J: Tumor necrosis factor receptors in neuroblastoma SKNBE cells and their regulation by retinoic acid. J Neurochem 1995, 65:537–544.PubMedCrossRef 40. López-Carballo G, Moreno L, Masiá S, Pérez P, Barettino D: Activation of the phosphatidylinositol 3-kinase/Akt signaling GSK458 pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 2002, 277:25297–25304.PubMedCrossRef 41. Cerignoli F, Ambrosi C, Mellone M, Assimi I, di Marcotullio L, Gulino A, Giannini G: HMGA molecules in neuroblastic tumors. Ann N Y Acad Sci 2004, 1028:122–132.PubMedCrossRef 42. Giannini G, Cerignoli F, Mellone M, Massimi I, Ambrosi C, Rinaldi C, Gulino A: Molecular mechanism of HMGA1 deregulation in human neuroblastoma. Cancer Lett 2005,
228:97–104.PubMedCrossRef 43. Choi Pazopanib cost LM, Rood B, Kamani N, La Fond D, Packer RJ, Santi MR, Macdonald TJ: Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors. Pediatr Blood Cancer 2008, 50:970–975.PubMedCrossRef 44. Wang R, Song D, Jing Y: Traditional Medicines Used in Differentiation Therapy of Myeloid Leukemia. Asian J Trad Med 2006, 1:37–44. 45. Korkina LG: Phenylpropanoids as naturally occurring antioxidants: From plant defense to human health. Cell Mol Biol 2007, 53:15–25.PubMed 46. Jaganathan SK, Mandal M: Antiproliferative Effects of Honey and of its Polyphenols: A Review. J Biomed Biotechnol 2009. Article ID: 830616. Competing interests The authors declare that they have no competing interests. Authors’ contributions PC carried out the experiments with cell lines, performed expression profiling and drafted the manuscript. MR participated in the experiments with cell lines and in the manuscript preparation.